Iterative Health Valuation, Funding & Investors

NantOmics is a Culver City-headquartered molecular diagnostics company that develops cloud-based molecular profiling tools, including the GPS Cancer test and OncoPlexDx Targeted Proteomic panel, to guide personalized cancer treatments for patients and oncologists. As a subsidiary of NantWorks, it delivers point-of-care insights into cancer biology through quantitative protein biomarkers and genomic profiles. NantOmics supports treatment strategies in clinical settings across the United States, with headquarters in California and integration into broader precision medicine platforms.

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity’s products and services are sold worldwide, with major markets in the US, Europe, and China.

Sinocare Inc operates in the healthcare industry. It is engaged in the development, manufacturing, and marketing of diagnosis testing products for people with chronic diseases and healthcare professionals. Its product range covers household blood glucose meter, medical blood glucose meter, urinary microalbumin test strip and blood lipid uric acid products. In addition, the company also provides diabetes management information systems.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Viz.ai is a San Francisco-based artificial intelligence company that develops a care-coordination platform for hospitals, using machine learning to analyze medical imaging such as CT scans and alert care teams to time-sensitive conditions. Originally focused on stroke detection, the platform has expanded to other conditions including pulmonary embolism and aortic disease, with FDA clearances and Medicare reimbursement supporting adoption. Viz.ai is deployed across more than 1,300 hospitals, connecting radiologists, emergency physicians, and specialists to speed diagnosis and treatment decisions.

United Imaging Intelligence is a provider of AI-driven medical solutions covering diagnostics for all diseases. Based in Shanghai, China, it develops full-stack intelligent software for imaging analysis, radiotherapy planning, and healthcare workflows, integrating with United Imaging Healthcare's hardware.

Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.

Twin Health is a Mountain View, California-headquartered digital health company offering an AI-driven Whole Body Digital Twin platform for metabolic disorders. The system uses wearable sensors to monitor glucose, activity, and sleep, generating personalized nutrition and lifestyle plans. Clinically validated to reverse type 2 diabetes, Twin Health operates clinics in the US and India.

iCarbonX is a Beijing-headquartered developer of AI-powered digital health ecosystems combining genomic sequencing, wearable data, and machine learning for personalized wellness. The platform analyzes multi-omics data from partnerships with BGI Genomics to deliver health risk scores, disease predictions, and lifestyle recommendations via mobile apps. iCarbonX focuses on chronic disease prevention through continuous monitoring of biomarkers like blood glucose and heart rate variability.

Porter is a Miami-headquartered analytics firm that processes big data for healthcare providers and consumer goods manufacturers. Launched in 2021, it delivers insights on patient outcomes and product performance through proprietary platforms. The company targets pharmaceutical firms and CPG brands seeking operational efficiencies in supply chains and market forecasting.

Welle is a digital health company based in New York providing personalized care plans to mitigate inflammation and chronic disease risks. Its platform uses at-home testing kits for biomarkers like hsCRP and offers nutrition, supplement, and lifestyle recommendations via app-based coaching. Welle targets corporate wellness programs and partners with employers in finance and tech sectors for employee health initiatives.

Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.

Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.

Cult.fit is a Bangalore-headquartered health and fitness company founded in 2016. It operates over 280 gyms across 50 Indian cities, delivering trainer-led classes in yoga, dance, strength training, and cycling. The platform provides nutrition plans via EatFit cloud kitchens, mental wellness through Cult.Mind, and primary care consultations, serving 2 million monthly active users.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

JMDC Inc is engaged in constructing and providing a medical database, offering PHR and other health promotion services, telemedicine such as diagnostic imaging, and providing digital solutions to dispensing pharmacies.